Hemodynamic Measurements of Macrocirculatory and Perfusion Parameters in ICU
Recruiting
Observational Study
Septic Shock
Hemodynamic Instability
Vasoconstriction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 45 (estimated)
- Sponsor
- Copenhagen University Hospital, Hvidovre · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In septic shock there is growing evidence of a state of hemodynamic "disconnection" with seemingly adequate macrocirculatory values despite actual microcirculation failing to meet cellular demand. Norepinephrine (NE) is recommended as first choice vasoactive agent for the treatment of septic shock. However, the dynamic effects of NE on macro- and microcirculation and perfusion parameters has not b…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Suspected or documented infection
* Need for vasopressors to maintain mean arterial blood pressure (MAP) ≥65 mmHg
* Serum lactate levels \>2 mmol/L
* Norepinephrine infusion of \> 0.2 mcg/kg/min
Exclusion Criteria:
* Absolute contraindication for esophageal doppler or urinar…
Contacts